The Egyptian Journal of Haematology

ORIGINAL ARTICLE
Year
: 2018  |  Volume : 43  |  Issue : 4  |  Page : 151--157

Prognostic significance of tetraspanin (CD81) expression in patients with acute myeloid leukemia


Ola A Elshoura1, Rasha A Elkholy1, Amal E Selim2, Nesreen M Sabry3 
1 Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt
2 Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt
3 Department of Clinical Oncology and Radiotherapy, Faculty of Medicine, Tanta University, Tanta, Egypt

Correspondence Address:
Rasha A Elkholy
Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta
Egypt

Objective The aim was to determine the prognostic significance of CD81 expression in patients with acute myeloid leukemia (AML) and its effect on patients’ survival. Patients and methods This study was carried out on 50 patients with newly diagnosed AML. Expression of CD81 was detected by flow cytometry, and then all the patients received chemotherapy and were observed for a period of 12 months regarding clinical and laboratory findings of remission and relapse. Results Our results showed that positive expression of CD81 was detected in 30/50 (60%) patients. Clinical remission was achieved in six (12%) patients with positive expression of CD81, whereas it was achieved in 12 (24%) patients with negative CD81 expression. Relapse occurred in 19 (38%) patients with positive expression of CD81, whereas it occurred in six (12%) patients with negative CD81 expression. Death occurred in five (10%) patients with positive expression of CD81 and in two (4%) patients with negative expression of CD81. Conclusion CD81 expression has a potential role as a prognostic marker as its expression was associated with patients with high-risk AML, with higher white blood cells, higher lactate dehydrogenase, and higher blast percentage in bone marrow, and M1 and M5 FAB subtypes. Decreased overall survival and disease-free survival in patients with CD81-positive expression than in patients with CD81-negative expression was also observed.


How to cite this article:
Elshoura OA, Elkholy RA, Selim AE, Sabry NM. Prognostic significance of tetraspanin (CD81) expression in patients with acute myeloid leukemia.Egypt J Haematol 2018;43:151-157


How to cite this URL:
Elshoura OA, Elkholy RA, Selim AE, Sabry NM. Prognostic significance of tetraspanin (CD81) expression in patients with acute myeloid leukemia. Egypt J Haematol [serial online] 2018 [cited 2019 Sep 20 ];43:151-157
Available from: http://www.ehj.eg.net/article.asp?issn=1110-1067;year=2018;volume=43;issue=4;spage=151;epage=157;aulast=Elshoura;type=0